Business Description
Pure Biologics SA
ISIN : PLPRBLG00010
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.28 | |||||
Equity-to-Asset | 0.08 | |||||
Debt-to-Equity | 6.84 | |||||
Debt-to-EBITDA | -0.5 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -8.87 | |||||
Beneish M-Score | -5.73 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -56 | |||||
3-Year EBITDA Growth Rate | -17.1 | |||||
3-Year EPS without NRI Growth Rate | -14.3 | |||||
3-Year FCF Growth Rate | -84.3 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.23 | |||||
9-Day RSI | 37.41 | |||||
14-Day RSI | 38.45 | |||||
6-1 Month Momentum % | -26.96 | |||||
12-1 Month Momentum % | -53.96 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3 | |||||
Quick Ratio | 3 | |||||
Cash Ratio | 0.5 | |||||
Days Sales Outstanding | 1072.72 | |||||
Days Payable | 428.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.2 | |||||
Shareholder Yield % | -76.49 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -2709.47 | |||||
Operating Margin % | -31381.05 | |||||
Net Margin % | -37572.63 | |||||
FCF Margin % | -24671.58 | |||||
ROE % | -213.22 | |||||
ROA % | -66.58 | |||||
ROIC % | -77.6 | |||||
ROC (Joel Greenblatt) % | -137.47 | |||||
ROCE % | -78.29 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 271.07 | |||||
PB Ratio | 13.34 | |||||
Price-to-Tangible-Book | 15.49 | |||||
EV-to-EBIT | -1.17 | |||||
EV-to-EBITDA | -1.41 | |||||
EV-to-Revenue | 317.34 | |||||
EV-to-FCF | -1.45 | |||||
Price-to-Net-Current-Asset-Value | 33 | |||||
Earnings Yield (Greenblatt) % | -85.45 | |||||
FCF Yield % | -111.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pure Biologics SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | 0.095 | ||
EPS (TTM) (zł) | -11.19 | ||
Beta | 0.8 | ||
Volatility % | 54.7 | ||
14-Day RSI | 38.45 | ||
14-Day ATR (zł) | 0.361797 | ||
20-Day SMA (zł) | 7.72 | ||
12-1 Month Momentum % | -53.96 | ||
52-Week Range (zł) | 5.01 - 21.9 | ||
Shares Outstanding (Mil) | 3.33 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pure Biologics SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pure Biologics SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Pure Biologics SA Frequently Asked Questions
What is Pure Biologics SA(WAR:PUR)'s stock price today?
When is next earnings date of Pure Biologics SA(WAR:PUR)?
Does Pure Biologics SA(WAR:PUR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |